Evidence map›Paper›PMID 35624762›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Styrylpyrones from

Chun-Hung Chiu, Chun-Chao Chang, Jia-Jing Lin, Chin-Chu Chen, Charng-Cherng Chyau, Robert Y Peng

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. A prospective clinical study on the effectiveness ofJournal of traditional and complementary medicine · 2026
    Article
  2. Article
  3. Review
  4. Inhibitory Effect of Styrylpyrone Extract ofInternational journal of molecular sciences · 2023
    Article
  5. Immunostimulatory Effect of Postbiotics Prepared fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chun-Hung ChiuResearch Institute of Biotechnology, Hungkuang University, Shalu District, Taichung City 43302, Taiwan.
Chun-Chao ChangDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 11031, Taiwan.ORCID 0000-0002-3396-1559
Jia-Jing LinResearch Institute of Biotechnology, Hungkuang University, Shalu District, Taichung City 43302, Taiwan.
Chin-Chu ChenBiotech Research Institute, GrapeKing Bio Ltd., Taoyuan 32542, Taiwan.
Charng-Cherng ChyauResearch Institute of Biotechnology, Hungkuang University, Shalu District, Taichung City 43302, Taiwan.ORCID 0000-0001-6801-5573
Robert Y PengResearch Institute of Biotechnology, Hungkuang University, Shalu District, Taichung City 43302, Taiwan.
Hungkuang University · TWGrape King (Taiwan) · TWTaipei Medical University · TWTaipei Medical University Hospital · TW

Funding

the Ministry of Science and Technology of the Republic of China MOST 109-2320-B-241-001- and 105-2320-B-241-002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

centrifugal partition chromatography (CPC)dyslipidemiahepatoprotectionhispidinhypholomine BmiceNAFLDPhellinus linteusstyrylpyrone polyphenolics

Identifiers

PMID35624762
PMCPMC9137645
OpenAlexW4225246967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.